Literature DB >> 33457118

Effect of Vitamin D3 Supplementation on Insulin Sensitivity in Prediabetes With Hypovitaminosis D: A Randomized Placebo-Controlled Trial.

Munibuddin M Ahmed1, Urjita S Zingade2, Khaled M Badaam1.   

Abstract

Introduction The interplay of vitamin D and glucose metabolism is an area of ongoing research. The need for vitamin D supplementation trials in individuals with prediabetes and hypovitaminosis D has been stressed by earlier research studies. The objective of this study was to assess the effect of vitamin D3 supplementation on oral glucose insulin sensitivity (OGIS) index in patients with prediabetes and hypovitaminosis D. Methods  We enrolled 120 individuals with prediabetes (ADA definition) and hypovitaminosis D (vitamin D < 30 ng/mL) and randomized them into the vitamin D supplementation (60,000 IU weekly) group and the placebo group. Primary outcome measure (i.e., 2-hour OGIS index) and secondary outcome measures (i.e., fasting and postprandial blood glucose, glycosylated hemoglobin, body mass index, and insulin sensitivity indices, i.e., quantitative insulin sensitivity check index [QUICKI] and homeostatic model assessment for insulin resistance [HOMA-IR]) were analyzed for change with the 12 weeks of intervention. Results  A total of 52 subjects in the vitamin D group and 49 in the placebo group completed the study. Serum vitamin D levels (10.11 ± 2.73 to 52.2 ± 13.14 ng/mL; p < 0.0001) and OGIS index (376.4 ± 39.7 to 391.7 ± 40.7 mL/min/m2; p = 0.011) increased significantly on per-protocol analysis in the vitamin D group. There was no significant change observed in vitamin D levels and OGIS index in the placebo group. Between-group comparison showed a rise in OGIS index (15.3 ± 47.1 mL/min/m2) in the vitamin D group and decrease in OGIS index (-10.4 ± 44.7 mL/min/m2) in the placebo group, and the difference was statistically significant (p = 0.0029). The inter-group comparison showed relative fall in fasting glucose levels in the vitamin D group, with no significant change observed in the other secondary outcome measures. Conclusions The correction of hypovitaminosis D in subjects with prediabetes led to improved insulin sensitivity as assessed by OGIS index at 120 minutes, signifying the role of vitamin D in glucose homeostasis.
Copyright © 2020, Ahmed et al.

Entities:  

Keywords:  25 (oh) vitamin d; glucose; glucose metabolism; impaired glucose tolerance; insulin resistance; oral glucose insulin sensitivity (ogis) index; type b insulin resistance; vitamin d; vitamin d deficiency

Year:  2020        PMID: 33457118      PMCID: PMC7797427          DOI: 10.7759/cureus.12009

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  29 in total

1.  Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test.

Authors:  A Mari; G Pacini; A R Brazzale; B Ahrén
Journal:  Diabetologia       Date:  2005-03-03       Impact factor: 10.122

Review 2.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

3.  EFFECT OF HIGH-DOSE VITAMIN D REPLETION ON GLYCEMIC CONTROL IN AFRICAN-AMERICAN MALES WITH PREDIABETES AND HYPOVITAMINOSIS D.

Authors:  Elena Barengolts; Buvana Manickam; Yuval Eisenberg; Arfana Akbar; Subhash Kukreja; Irina Ciubotaru
Journal:  Endocr Pract       Date:  2015-02-25       Impact factor: 3.443

4.  Effect of vitamin D supplementation on fasting plasma glucose, insulin resistance and prevention of type 2 diabetes mellitus in non-diabetics: A systematic review and meta-analysis.

Authors:  Sitian He; Songcheng Yu; Zonglei Zhou; Chongjian Wang; Yongjun Wu; Wenjie Li
Journal:  Biomed Rep       Date:  2018-03-09

5.  Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3).

Authors:  B Maestro; S Molero; S Bajo; N Dávila; C Calle
Journal:  Cell Biochem Funct       Date:  2002-09       Impact factor: 3.685

6.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

Authors:  Ken C Chiu; Audrey Chu; Vay Liang W Go; Mohammed F Saad
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

7.  A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.

Authors:  J Nagpal; J N Pande; A Bhartia
Journal:  Diabet Med       Date:  2009-01       Impact factor: 4.359

8.  An open-label, randomized, 10 weeks prospective study on the efficacy of vitamin D (daily low dose and weekly high dose) in vitamin D deficient patients.

Authors:  Vikram Singh; Arup K Misra; Mridu Singh; Naresh K Midha; Bharat Kumar; Sneha Ambwani; Gopal K Bohra; Pramod K Sharma
Journal:  J Family Med Prim Care       Date:  2019-06

9.  Diabetes Prevention: Vitamin D Supplementation May Not Provide Any Protection If There Is No Evidence of Deficiency!

Authors:  Uwe Gröber; Michael F Holick
Journal:  Nutrients       Date:  2019-11-04       Impact factor: 5.717

10.  A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum.

Authors:  Robert P Heaney; Christine B French; Stacie Nguyen; Mia Ferreira; Leo L Baggerly; Ludovic Brunel; Paul Veugelers
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

View more
  2 in total

1.  Effect of Vitamin D Supplementation on Glycemic Control in Prediabetes: A Meta-Analysis.

Authors:  Yujing Zhang; Yuan Xue; Dongdong Zhang; Yaping Liu; Ze Xu; Jiaojiao Gao; Wenjie Li; Xing Li
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

2.  25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation.

Authors:  Hanyuan Xu; Guiyan Han; Linjie Wang; Huihua Ding; Chunyan Wang; Xiaochuan Ping; Caixia Dong; Dianxi Zhang; Yufei Dai; Naishi Li; Yufeng Li; Hongbo Yang; Huijuan Zhu; Hui Pan; Fengying Gong; Jichun Chen; Xiaoping Xing
Journal:  Diabetol Metab Syndr       Date:  2022-01-29       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.